Literature DB >> 23369395

The need for ethical reflection on the use of molecular microbial characterisation in outbreak management.

B Rump1, C Cornelis, F Woonink, M Verweij.   

Abstract

Current thinking on the development of molecular microbial characterisation techniques in public health focuses mainly on operational issues that need to be resolved before incorporation into daily practice can take place. Notwithstanding the importance of these operational challenges, it is also essential to formulate conditions under which such microbial characterisation methods can be used from an ethical perspective. The potential ability of molecular techniques to show relational patterns between individuals with more certainty brings a new sense of urgency to already difficult ethical issues associated with privacy, consent and a moral obligation to avoid spreading a disease. It is therefore important that professionals reflect on the ethical implications of using these techniques in outbreak management, in order to be able to formulate the conditions under which they may be applied in public health practice.

Mesh:

Year:  2013        PMID: 23369395     DOI: 10.2807/ese.18.04.20384-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  3 in total

1.  Using typing techniques in a specific outbreak: the ethical reflection of public health professionals.

Authors:  B Rump; C Cornelis; F Woonink; J VAN Steenbergen; M Verweij; M Hulscher
Journal:  Epidemiol Infect       Date:  2017-02-13       Impact factor: 4.434

2.  Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice.

Authors:  Gail Geller; Rachel Dvoskin; Chloe L Thio; Priya Duggal; Michelle H Lewis; Theodore C Bailey; Andrea Sutherland; Daniel A Salmon; Jeffrey P Kahn
Journal:  Genome Med       Date:  2014-11-18       Impact factor: 11.117

Review 3.  Genomics and outbreak investigation: from sequence to consequence.

Authors:  Esther R Robinson; Timothy M Walker; Mark J Pallen
Journal:  Genome Med       Date:  2013-04-29       Impact factor: 11.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.